DRUG
Income statement / Annual
Last year (2024), Bright Minds Biosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Bright Minds Biosciences Inc.'s net income was -$2.80 M.
See Bright Minds Biosciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.18 M
|
$5.00 M
|
$12.18 M
|
$6.31 M
|
$354,852.00
|
$126,027.00
|
| General & Administrative Expenses |
$1.40 M
|
$2.08 M
|
$2.00 M
|
$1.46 M
|
$110,456.00
|
$110,124.00
|
| Selling & Marketing Expenses |
$41,600.00
|
$119,418.00
|
$551,864.00
|
$852,151.00
|
$9,618.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.44 M
|
$2.20 M
|
$2.55 M
|
$2.31 M
|
$120,074.00
|
$110,124.00
|
| Other Expenses |
$0.00
|
$0.00
|
-$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.62 M
|
$7.20 M
|
$14.73 M
|
$8.62 M
|
$474,926.00
|
$236,151.00
|
| Cost And Expenses |
$2.62 M
|
$7.20 M
|
$14.73 M
|
$8.62 M
|
$474,926.00
|
$236,151.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.62 M
|
$72,450.00
|
$6,037.00
|
$8.62 M
|
$474,926.00
|
$236,151.00
|
| EBITDA |
$0.00 |
-$7.28 M |
-$14.96 M |
$0.00 |
$0.00 |
$0.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$185,310.00
|
-$172,462.00
|
-$232,928.00
|
-$27,644.00
|
-$5,451.00
|
$0.00
|
| Income Before Tax |
-$2.80 M
|
-$7.37 M
|
-$14.96 M
|
-$8.65 M
|
-$480,377.00
|
-$236,151.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$2.80 M
|
-$7.37 M
|
-$14.96 M
|
-$8.65 M
|
-$480,377.00
|
-$236,151.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.65 |
-1.98 |
-6.15 |
-4.74 |
-0.38 |
-0.0615 |
| EPS Diluted |
-0.65 |
-1.98 |
-6.15 |
-4.74 |
-0.38 |
-0.0615 |
| Weighted Average Shares Out |
$4.31 M
|
$3.72 M
|
$2.47 M
|
$1.79 M
|
$1.28 M
|
$1.28 M
|
| Weighted Average Shares Out Diluted |
$4.31 M
|
$3.72 M
|
$2.47 M
|
$1.79 M
|
$1.28 M
|
$1.28 M
|
| Link |
|
|
|
|
|
|
